Guanze Medical Information Industry (Holding) Co., Ltd. released its Monthly Return for Equity Issuer for the period ended 31 July 2026, confirming stable share capital metrics and ongoing compliance with Hong Kong’s public float rules.

The authorised share structure remained unchanged at 10.00 billion ordinary shares with a par value of HKD 0.01 each, representing authorised capital of HKD 100.00 million.

Issued share capital also held steady. The company closed the month with 950.00 million issued shares and no treasury shares, identical to the previous month’s figures.

Management affirmed that the public float continues to satisfy the Main Board’s Initial Prescribed Threshold of 25% of issued shares.

The filing disclosed no activity in share options, warrants, convertibles, or other share-issuing agreements during the month, indicating no dilution or capital structure alterations.

The return was signed by Company Secretary Cheng Cheung King and submitted to Hong Kong Exchanges and Clearing Limited on 06 August 2026.